TFX vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

TFX

47.7
AI Score
VS
XRAY Wins

XRAY

51.6
AI Score

Investment Advisor Scores

TFX

48score
Recommendation
HOLD

XRAY

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric TFX XRAY Winner
Revenue 1.12B 1.78B XRAY
Net Income 91.54M 27.00M TFX
Gross Margin 57.1% 51.7% TFX
Net Margin 8.2% 1.5% TFX
Operating Income 93.01M 47.00M TFX
ROE 3.2% 2.0% TFX
ROA 1.3% 0.5% TFX
Total Assets 6.79B 5.20B TFX
Cash 300.16M 239.00M TFX
Debt/Equity 0.97 1.48 TFX
Current Ratio 2.60 1.63 TFX

Relative Price Performance (Last 90 Days)

TFX 1M: -4.7% · 3M: +0.5% XRAY 1M: -8.5% · 3M: +2.9%

Current Technical Phase

TFX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 37

RSI (14): 36.7 · Price: $129.91

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 35.4 · Price: $10.44

Fundamentals Snapshot

Metric TFX XRAY
Market Cap
Forward P/E 12.1 6.9
Trailing P/E
Revenue (TTM)
Revenue Growth 0.3% 0.0%
Gross Margin 0.6% 0.5%
Operating Margin 0.1% 0.1%
EPS -0.53 -2.73
Dividend Yield 0.01% 0.03%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.